Researchers from the University of British Columbia and McMaster University have developed what could be the bone implant material of the future: an airy, foamlike substance that can be injected into the body and provide scaffolding for the growth of new bone. It’s made by treating nanocrystals derived from plant cellulose so that they link up and form a strong…
Read More
There’s a growing belief that a blood test could act as a crystal ball in predicting a person’s necessity, response, and ultimate outcome to cancer treatment. According to BC Cancer researchers, blood can contain tiny fragments of DNA from an individual’s cancer and those fragments provide incredible insight into the patient’s journey. Imagine a simple blood test guiding your treatment:…
Read More
Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced a partnership with Mitacs for a multi-year cancer research project at the University of British Columbia (UBC).  Mitacs, a not-for-profit organization that fosters growth and innovation, will provide equal funding for research efforts at UBC that will directly support Pascal’s leading cancer development programs.…
Read More
The Research Excellence Clusters program at the University of British Columbia continues to support research across disciplines, linking the neuroscience community with experts across campus to ask big questions and solve big problems. In 2019, the program funded three clusters lead by researchers affiliated with the Djavad Mowafaghian Centre for Brain Health. The Dynamic Brain Circuits in Health and Disease Cluster(PI: Dr.…
Read More
The first week of a newborn’s life is a time of the most rapid biological change in life as the baby adapts to living outside the womb, suddenly exposed to new challenges including bacteria and viruses. Yet surprisingly little is known about these early changes. An international research team co-led by the University of British Columbia has pioneered a technique…
Read More
AbCellera today announced a two-year agreement with the Bill & Melinda Gates Foundation to help accelerate global health research. The funding, totaling $4.8 M, will support a series of scientific collaborations between AbCellera and Gates Foundation-funded scientists working on the prevention and treatment of high-priority infectious diseases. The target diseases – including HIV, malaria, and tuberculosis – infect hundreds of millions…
Read More
Maker Nation: Julio Montaner literally caused thousands of AIDS patients to rise from their death beds Canada has a rich history of innovation, but in the next few decades, powerful technological forces will transform the global economy. Large multinational companies have jumped out to a headstart in the race to succeed, and Canada runs the risk of falling behind. At…
Read More

BC-CfE Applauds Advance towards an HIV Cure

The BC-CfE is optimistic about the encouraging announcement that a second person has been cleared of HIV. As in the first case, this was achieved through a bone-marrow transplant from a donor harbouring a rare mutation in the human CCR5 gene. The CCR5 is necessary for HIV to enter cells in the human body as it acts as a receptor.…
Read More
Innovate BC, a Crown agency that connects local innovators with government funding, resources, and support, has awarded $613,850 in round six of its Ignite Program to spark the commercialization of technologies that will solve industry problems in the natural resources and applied sciences. Three BC research projects in diverse fields such as clean technology, biotech, and marine technology will split the funding. To date,…
Read More
“Microbiota” seems to be the buzz word in today’s research, but what is the microbiota and why are researchers so intent on learning more about it? The microbiota is the group of microorganisms living within an individual or in a specific environment. It has become the focus of many research papers as the microbiota can help determine health and overall…
Read More